ESC 365 - Is the transesophageal echocardiography mandatory in patients undergoing atrial fibrillation ablation with uninterrupted novel anticoagulants?

EHRA Premium Access

Is the transesophageal echocardiography mandatory in patients undergoing atrial fibrillation ablation with uninterrupted novel anticoagulants?

Session: Moderated Poster session 5 - Treatment strategies and ablation outcome

Topic: Catheter ablation (Atrial Fibrillation)

Speaker: Mrs A. Shapieva (Moscow, RU)

Event: EHRA EUROPACE - CARDIOSTIM 2017

Congress Presentation

Add to my library

About the speaker

Mrs Albina Shapieva

Petrovsky National Research Center of Surgery, Moscow (Russian Federation)

0 follower

7 more presentations in this session

Efficacy of non-vitamin k antagonist oral anticoagulants for perioperative complication in patients with atrial fibrillation undergoing catheter ablation.

Speaker: Doctor T. Iseda (Wakayama, JP)

Predictors of serious complications during and immediately after catheter ablation of atrial fibrillation in 8302 procedures: J-CARAF Study

Speaker: Professor Y. Murakawa (Kawasaki, JP)

The incidence of complications in the setting of second-generation cryoballoon ablation of atrial fibrillation: a comparison between vitamin K antagonists and novel oral anticoagulants

Long-term outcomes of supraventricular tachycardia ablation in congenital heart disease: single centre uk experience

Speaker: Doctor V. Sawhney (London, GB)

Long-term outcomes after catheter ablation of ventricular tachycardia in patients with structural heart disease: a Multicentre UK Study

Speaker: Doctor A. Breitenstein (Zurich, CH)

Access the full session

Moderated Poster session 5 - Treatment strategies and ablation outcome

Speakers: Mrs A. Shapieva, Doctor T. Iseda, Professor Y. Murakawa, Doctor V. Sawhney, Doctor A. Breitenstein

About the event

EHRA EUROPACE - CARDIOSTIM 2017

18 June - 21 June 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources